arrow
S

Scott Helton

Virginia Mason Medical Center
H指数:18
被引数:1,251

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome
2024-07-010
OAAI
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review
2023-04-170
PRE
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review
2023-04-0538
OAAI
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome
2023-03-307
OA
Model to predict major complications following liver resection for HCC in patients with metabolic syndrome

代谢综合征患者肝癌肝切除术后主要并发症的预测模型

2023-01-0312
PRE
Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

基于吉西他滨的可切除胰腺导管腺癌新辅助治疗: 个体患者数据的荟萃分析

2020-08-1112
OAAI